Skip to main content

D. E. Shaw & Co., Inc.

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in INO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,486,821
-$2,363,484 QoQ
Shares Held
1,351,656
-38.9% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 101 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Mar 31, 2021
CallValue
$0
CallShares
0
PutValue
$927,999
PutShares
8,333

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. INO ranks #144 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,486,821 1,351,656
2026-03-31 $3,850,305 2,212,819
2025-12-31 $3,883,351 2,231,811
2025-09-30 $1,887,776 806,742
2023-12-31 $1,377,592 2,701,162
2023-09-30 $2,152,345 5,518,837
2023-06-30 $3,420,959 7,602,133
2023-03-31 $5,427,451 6,618,844
2022-12-31 $13,214,291 8,470,700
2022-09-30 $13,062,967 7,550,849
2022-06-30 $10,376,972 5,998,250
2022-03-31 $19,744,363 5,499,823
2021-12-31 $29,867,809 5,985,533
2021-09-30 $27,156,855 3,792,857
2021-06-30 $19,373,010 2,089,861
2021-03-31 $927,999 100,000
2021-03-31 $8,467,099 912,403
2020-12-31 $7,831,444 884,909
2020-09-30 $3,303,343 284,771
2020-06-30 $11,591,194 430,100